Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ)

· *Johnson & Johnson announced Monday that it identified a lead COVID-19 vaccine candidate that could begin human trials in September and be ready for emergency authorization use in 2021. *
· *Shares of the healthcare company surged as much as 9% during regular trading.*
· *J&J will expand manufacturing capacity to produce...